JP2015512441A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015512441A5 JP2015512441A5 JP2015504545A JP2015504545A JP2015512441A5 JP 2015512441 A5 JP2015512441 A5 JP 2015512441A5 JP 2015504545 A JP2015504545 A JP 2015504545A JP 2015504545 A JP2015504545 A JP 2015504545A JP 2015512441 A5 JP2015512441 A5 JP 2015512441A5
- Authority
- JP
- Japan
- Prior art keywords
- acrylic resin
- eudragit
- resin polymer
- composition
- immunological composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 claims 13
- 238000000034 method Methods 0.000 claims 12
- 229920000178 Acrylic resin Polymers 0.000 claims 8
- 239000004925 Acrylic resin Substances 0.000 claims 8
- 229920000642 polymer Polymers 0.000 claims 8
- JIGUQPWFLRLWPJ-UHFFFAOYSA-N Ethyl acrylate Chemical compound CCOC(=O)C=C JIGUQPWFLRLWPJ-UHFFFAOYSA-N 0.000 claims 6
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 claims 6
- PNJWIWWMYCMZRO-UHFFFAOYSA-N pent‐4‐en‐2‐one Natural products CC(=O)CC=C PNJWIWWMYCMZRO-UHFFFAOYSA-N 0.000 claims 6
- 230000001900 immune effect Effects 0.000 claims 5
- 239000002671 adjuvant Substances 0.000 claims 3
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 claims 3
- 229910052782 aluminium Inorganic materials 0.000 claims 3
- 239000000427 antigen Substances 0.000 claims 3
- 102000036639 antigens Human genes 0.000 claims 3
- 108091007433 antigens Proteins 0.000 claims 3
- 229920001577 copolymer Polymers 0.000 claims 3
- ZAFFWOKULJCCSA-UHFFFAOYSA-N ethyl 2-methylprop-2-enoate;trimethylazanium;chloride Chemical compound [Cl-].C[NH+](C)C.CCOC(=O)C(C)=C ZAFFWOKULJCCSA-UHFFFAOYSA-N 0.000 claims 3
- 238000009472 formulation Methods 0.000 claims 3
- 102000003930 C-Type Lectins Human genes 0.000 claims 2
- 108090000342 C-Type Lectins Proteins 0.000 claims 2
- 229920003135 Eudragit® L 100-55 Polymers 0.000 claims 2
- 229920003156 Eudragit® RL PO Polymers 0.000 claims 2
- 229920003160 Eudragit® RS PO Polymers 0.000 claims 2
- 239000000556 agonist Substances 0.000 claims 2
- 238000001035 drying Methods 0.000 claims 2
- GDCRSXZBSIRSFR-UHFFFAOYSA-N ethyl prop-2-enoate;2-methylprop-2-enoic acid Chemical group CC(=C)C(O)=O.CCOC(=O)C=C GDCRSXZBSIRSFR-UHFFFAOYSA-N 0.000 claims 2
- 238000004108 freeze drying Methods 0.000 claims 2
- 230000002163 immunogen Effects 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 239000000843 powder Substances 0.000 claims 2
- 239000007921 spray Substances 0.000 claims 2
- 239000000725 suspension Substances 0.000 claims 2
- 229960005486 vaccine Drugs 0.000 claims 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims 1
- 229930195725 Mannitol Natural products 0.000 claims 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical group [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 claims 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims 1
- 229930006000 Sucrose Natural products 0.000 claims 1
- 239000000872 buffer Substances 0.000 claims 1
- 239000007853 buffer solution Substances 0.000 claims 1
- 150000001720 carbohydrates Chemical group 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 230000001419 dependent effect Effects 0.000 claims 1
- 238000007710 freezing Methods 0.000 claims 1
- FAHBNUUHRFUEAI-UHFFFAOYSA-M hydroxidooxidoaluminium Chemical group O[Al]=O FAHBNUUHRFUEAI-UHFFFAOYSA-M 0.000 claims 1
- 230000005847 immunogenicity Effects 0.000 claims 1
- 239000003446 ligand Substances 0.000 claims 1
- 239000000594 mannitol Substances 0.000 claims 1
- 235000010355 mannitol Nutrition 0.000 claims 1
- 239000008363 phosphate buffer Substances 0.000 claims 1
- 229920000058 polyacrylate Polymers 0.000 claims 1
- 235000017281 sodium acetate Nutrition 0.000 claims 1
- 239000001632 sodium acetate Substances 0.000 claims 1
- 239000000243 solution Substances 0.000 claims 1
- 238000005507 spraying Methods 0.000 claims 1
- 239000005720 sucrose Substances 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261686372P | 2012-04-04 | 2012-04-04 | |
| US61/686,372 | 2012-04-04 | ||
| PCT/US2013/000102 WO2013151595A1 (en) | 2012-04-04 | 2013-04-03 | Improved adjuvant system for oral vaccine adminstration |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015512441A JP2015512441A (ja) | 2015-04-27 |
| JP2015512441A5 true JP2015512441A5 (enExample) | 2015-09-17 |
| JP6240155B2 JP6240155B2 (ja) | 2017-11-29 |
Family
ID=49300897
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015504545A Active JP6240155B2 (ja) | 2012-04-04 | 2013-04-03 | 経口ワクチン投与のための改善アジュバント系 |
Country Status (10)
| Country | Link |
|---|---|
| US (3) | US20150079130A1 (enExample) |
| EP (2) | EP3549605A1 (enExample) |
| JP (1) | JP6240155B2 (enExample) |
| KR (1) | KR101867428B1 (enExample) |
| AU (1) | AU2013243971B2 (enExample) |
| CA (1) | CA2903313C (enExample) |
| DK (1) | DK2833914T3 (enExample) |
| IL (1) | IL234937B (enExample) |
| MX (1) | MX364946B (enExample) |
| WO (1) | WO2013151595A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3107568B1 (en) * | 2014-02-20 | 2024-03-27 | Vaxart, Inc. | Formulations for small intestinal delivery |
| CA2988165C (en) * | 2014-06-20 | 2023-08-01 | University Of Saskatchewan | Exotoxin/thermolysin compositions and methods and uses for treating or preventing laminitis |
| KR102773575B1 (ko) | 2015-06-12 | 2025-02-27 | 박사르트, 인크. | Rsv 및 노로바이러스 항원들의 소장 내의 전달을 위한 제형들 |
| WO2017153316A1 (en) * | 2016-03-07 | 2017-09-14 | Glaxosmithkline Biologicals Sa | Drug delivery particles |
| KR20200144120A (ko) * | 2018-04-16 | 2020-12-28 | 메르크 파텐트 게엠베하 | 열 안정성을 개선하기 위한 단백질 제제에 대한 첨가제 |
| KR102369740B1 (ko) | 2020-09-21 | 2022-03-02 | 부경대학교 산학협력단 | 자궁경부암 조기진단을 위한 모바일 질확대경 장치 |
| WO2022094816A1 (en) * | 2020-11-04 | 2022-05-12 | Janssen Pharmaceuticals, Inc. | Solid formulation |
| CN113750228B (zh) * | 2021-09-25 | 2024-02-20 | 大连理工大学 | 一种冷冻保护剂在铝佐剂中的应用 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU4133397A (en) * | 1996-10-28 | 1998-05-22 | Pfizer Inc. | Oral vaccines for young animals with an enteric coating |
| ATE284613T1 (de) * | 1997-02-14 | 2005-01-15 | Merck & Co Inc | Polynukleotid-impfstoff-formulierungen |
| US7087235B2 (en) | 1997-06-25 | 2006-08-08 | The United States Of America As Represented By The Secretary Of The Army | Fusion protein of streptococcal pyrogenic exotoxins |
| US20030162955A1 (en) * | 1998-03-17 | 2003-08-28 | Lionel Chalus | Isolated mammalian membrane protein genes; related reagents |
| PL193805B1 (pl) * | 1998-07-08 | 2007-03-30 | Kirin Amgen Inc | Preparat w postaci proszku do podawania przez błonę śluzową |
| EP1046651A1 (en) * | 1999-04-19 | 2000-10-25 | Koninklijke Universiteit Nijmegen | Composition and method for modulating dendritic cell-T interaction |
| CA2496384C (en) * | 2002-08-20 | 2016-11-01 | Genitrix, Llc | Lectin compositions and methods for modulating an immune response to an antigen |
| US20040213745A1 (en) * | 2003-02-20 | 2004-10-28 | Vincent Sullivan | Powder formulations of rSEB for improved vaccination |
| GB0505518D0 (en) * | 2005-03-17 | 2005-04-27 | Chiron Srl | Combination vaccines with whole cell pertussis antigen |
| AU2007300543A1 (en) * | 2006-09-26 | 2008-04-03 | Alexion Pharmaceuticals, Inc. | Compositions and methods for enhancing an adjuvant |
| WO2011018504A2 (en) * | 2009-08-12 | 2011-02-17 | Sigmoid Pharma Limited | Immunomodulatory compositions comprising a polymer matrix and an oil phase |
| GB0919690D0 (en) * | 2009-11-10 | 2009-12-23 | Guy S And St Thomas S Nhs Foun | compositions for immunising against staphylococcus aureus |
| GB201101665D0 (en) * | 2011-01-31 | 2011-03-16 | Novartis Ag | Immunogenic compositions |
-
2013
- 2013-04-03 DK DK13772028.0T patent/DK2833914T3/en active
- 2013-04-03 WO PCT/US2013/000102 patent/WO2013151595A1/en not_active Ceased
- 2013-04-03 JP JP2015504545A patent/JP6240155B2/ja active Active
- 2013-04-03 CA CA2903313A patent/CA2903313C/en active Active
- 2013-04-03 AU AU2013243971A patent/AU2013243971B2/en not_active Ceased
- 2013-04-03 KR KR1020147030919A patent/KR101867428B1/ko not_active Expired - Fee Related
- 2013-04-03 US US13/261,964 patent/US20150079130A1/en not_active Abandoned
- 2013-04-03 EP EP19151134.4A patent/EP3549605A1/en not_active Withdrawn
- 2013-04-03 MX MX2014011806A patent/MX364946B/es active IP Right Grant
- 2013-04-03 EP EP13772028.0A patent/EP2833914B1/en active Active
-
2014
- 2014-10-02 IL IL234937A patent/IL234937B/en unknown
-
2018
- 2018-12-06 US US16/212,088 patent/US20190105389A1/en not_active Abandoned
-
2020
- 2020-11-05 US US17/090,292 patent/US20210052725A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015512441A5 (enExample) | ||
| JP6953478B2 (ja) | 回腸及び虫垂に対して活性の胃腸部位特異的経口ワクチン接種製剤 | |
| JP2017523180A5 (enExample) | ||
| ES2307044T3 (es) | Forma de medicamento multicapa que contiene una sustancia con actividad moduladora en lo que respeta a la liberacion del principio activo. | |
| KR101387835B1 (ko) | 코팅된 제약 제형을 제조하기 위한 중합체 혼합물의 용도및 혼합된 중합체성 코팅을 갖는 제약 제형 | |
| JP2018521028A5 (enExample) | ||
| JP2018162284A5 (ja) | 複数の被覆された粒子を含む組成物及び医薬製剤 | |
| Jain et al. | Expedition of Eudragit® polymers in the development of novel drug delivery systems | |
| HRP20230305T1 (hr) | Pripravci za ileo-jejunalnu dostavu lijeka | |
| JP2009530298A5 (enExample) | ||
| JP2018533547A (ja) | ワクチン組成物 | |
| JP2012097088A5 (enExample) | ||
| KR20130064741A (ko) | 비강내 전달을 위한 방법 및 조성물 | |
| KR20080024200A (ko) | 감소된 ｐＨ 값에서 활성 성분을 방출하는 약제를 제조하기위한 코팅으로서의 부분 중화된음이온（메트）아크릴레이트 공중합체의 용도 | |
| JP2015519330A5 (enExample) | ||
| KR102381586B1 (ko) | 메살라진의 경구용 약제학적 조성물 | |
| JP2013518052A5 (enExample) | ||
| JP2020063290A (ja) | 放出調節コーティングカプセル | |
| WO2018072709A1 (zh) | 医药微丸的干粉包衣组合物 | |
| DK2833914T3 (en) | ADMINISTRATIVE SYSTEM FOR ORAL VACCINE ADMINISTRATION | |
| JP2020063295A (ja) | 放出調節コーティングカプセル | |
| CN104274830A (zh) | 一种基于抗原共价结合壳聚糖纳米粒的鼻腔免疫载体 | |
| CN102579408A (zh) | 盐酸多西环素双释放制剂及其制备方法 | |
| JP2019534897A5 (enExample) | ||
| CN109152772B (zh) | 烟酰胺的口服药物组合物 |